These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 32198165)

  • 1. Flash glucose monitoring reduces glycemic variability and hypoglycemia: real-world data from Spain.
    Gomez-Peralta F; Dunn T; Landuyt K; Xu Y; Merino-Torres JF
    BMJ Open Diabetes Res Care; 2020 Mar; 8(1):. PubMed ID: 32198165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Flash Glucose Monitoring in Israel: Understanding Real-World Associations between Self-Monitoring Frequency and Metrics of Glycemic Control.
    Eldor R; Roitman E; Merzon E; Toledano Y; Alves C; Tsur A
    Endocr Pract; 2022 May; 28(5):472-478. PubMed ID: 35167952
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Real-world flash glucose monitoring patterns and associations between self-monitoring frequency and glycaemic measures: A European analysis of over 60 million glucose tests.
    Dunn TC; Xu Y; Hayter G; Ajjan RA
    Diabetes Res Clin Pract; 2018 Mar; 137():37-46. PubMed ID: 29278709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Flash Glucose Monitoring in the Netherlands: Increased monitoring frequency is associated with improvement of glycemic parameters.
    Lameijer A; Lommerde N; Dunn TC; Fokkert MJ; Edens MA; Kao K; Xu Y; Gans ROB; Bilo HJG; van Dijk PR
    Diabetes Res Clin Pract; 2021 Jul; 177():108897. PubMed ID: 34098059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Albuminuria, glycemic variability and effect of flash glucose monitoring based decision making on short term glycemic variability in Indian type 2 diabetes patients: Indi-GlyVar study.
    Nathiya D; Singh M; Suman S; Bareth H; Pal N; Jain A; Tomar BS
    Front Endocrinol (Lausanne); 2022; 13():1011411. PubMed ID: 36465630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Real-world flash glucose monitoring in Brazil: can sensors make a difference in diabetes management in developing countries?
    Calliari LEP; Krakauer M; Vianna AGD; Ram Y; Barbieri DE; Xu Y; Dunn TC
    Diabetol Metab Syndr; 2020; 12():3. PubMed ID: 31921360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Real world hypoglycaemia related to glucose variability and Flash glucose scan frequency assessed from global FreeStyle Libre data.
    Riveline JP; Wojtusciszyn A; Guerci B; Alves C; Kao K; Xu Y; Dunn TC
    Diabetes Obes Metab; 2022 Nov; 24(11):2102-2107. PubMed ID: 35695037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between scanning frequency of flash glucose monitoring and continuous glucose monitoring-derived glycemic makers in children and adolescents with type 1 diabetes.
    Suzuki J; Urakami T; Yoshida K; Kuwabara R; Mine Y; Aoki M; Morioka I
    Pediatr Int; 2021 Feb; 63(2):154-159. PubMed ID: 32744360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Measures of Glycemic Variability in Type 1 Diabetes and the Effect of Real-Time Continuous Glucose Monitoring.
    El-Laboudi AH; Godsland IF; Johnston DG; Oliver NS
    Diabetes Technol Ther; 2016 Dec; 18(12):806-812. PubMed ID: 27996321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of flash glucose-sensing technology (FreeStyle Libre) in youth with type 1 diabetes: AWeSoMe study group real-life observational experience.
    Landau Z; Abiri S; Gruber N; Levy-Shraga Y; Brener A; Lebenthal Y; Barash G; Pinhas-Hamiel O; Rachmiel M
    Acta Diabetol; 2018 Dec; 55(12):1303-1310. PubMed ID: 30171412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Flash glucose monitoring improves glycemia in higher risk patients: a longitudinal, observational study under real-life settings.
    Jangam S; Dunn T; Xu Y; Hayter G; Ajjan RA
    BMJ Open Diabetes Res Care; 2019; 7(1):e000611. PubMed ID: 31114698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intermittently Scanned Continuous Glucose Monitoring Data of Polish Patients from Real-Life Conditions: More Scanning and Better Glycemic Control Compared to Worldwide Data.
    Hohendorff J; Gumprecht J; Mysliwiec M; Zozulinska-Ziolkiewicz D; Malecki MT
    Diabetes Technol Ther; 2021 Aug; 23(8):577-585. PubMed ID: 33794101
    [No Abstract]   [Full Text] [Related]  

  • 13. Improvement in glycemic excursions with a transcutaneous, real-time continuous glucose sensor: a randomized controlled trial.
    Garg S; Zisser H; Schwartz S; Bailey T; Kaplan R; Ellis S; Jovanovic L
    Diabetes Care; 2006 Jan; 29(1):44-50. PubMed ID: 16373894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glucose Variability: A Review of Clinical Applications and Research Developments.
    Rodbard D
    Diabetes Technol Ther; 2018 Jun; 20(S2):S25-S215. PubMed ID: 29916742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of daily glycemic profiles in well controlled children with type 1 diabetes mellitus using a continuous glucose monitoring system.
    Tucholski K; Deja G; Skała-Zamorowska E; Jarosz-Chobot P
    Pediatr Endocrinol Diabetes Metab; 2009; 15(1):29-33. PubMed ID: 19454186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frequency of flash glucose monitoring and glucose metrics: real-world observational data from Saudi Arabia.
    Al-Harbi MY; Albunyan A; Alnahari A; Kao K; Brandner L; El Jammal M; Dunn TC
    Diabetol Metab Syndr; 2022 May; 14(1):66. PubMed ID: 35501880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of scan frequency with CGM-derived metrics and influential factors in adults with type 1 diabetes mellitus.
    Sakane N; Hirota Y; Yamamoto A; Miura J; Takaike H; Hoshina S; Toyoda M; Saito N; Hosoda K; Matsubara M; Tone A; Kawashima S; Sawaki H; Matsuda T; Domichi M; Suganuma A; Sakane S; Murata T
    Diabetol Int; 2024 Jan; 15(1):109-116. PubMed ID: 38264231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of strict COVID-19 lockdown in Spain on glycemic profiles in patients with type 1 Diabetes prone to hypoglycemia using standalone continuous glucose monitoring.
    Mesa A; Viñals C; Pueyo I; Roca D; Vidal M; Giménez M; Conget I
    Diabetes Res Clin Pract; 2020 Sep; 167():108354. PubMed ID: 32739380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of beta-glucan supplementation on glycemic control and variability in adolescents with type 1 diabetes mellitus.
    Bozbulut R; Şanlıer N; Döğer E; Bideci A; Çamurdan O; Cinaz P
    Diabetes Res Clin Pract; 2020 Nov; 169():108464. PubMed ID: 32971156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hemodialysis-Related Glycemic Disarray Proven by Continuous Glucose Monitoring; Glycemic Markers and Hypoglycemia.
    Hayashi A; Shimizu N; Suzuki A; Matoba K; Momozono A; Masaki T; Ogawa A; Moriguchi I; Takano K; Kobayashi N; Shichiri M
    Diabetes Care; 2021 Jul; 44(7):1647-1656. PubMed ID: 34045240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.